52-Week Performance Chart

Powered by FactSet Research Systems Inc

Corporate Actions/Books Closed

More
Feb 23, 2024
Trinity Biotech plc - Books Re-opened Announcement
Feb 15, 2024
Trinity Biotech PLC - Ratio Change and Reverse Split - Revised Effective Date
Feb 13, 2024
Trinity Biotech PLC - Ratio Change and Reverse Split

Capital Raising Events

More
DR Price Date DR Price (USD) US/Non-US/Total DRS US/Non-US/Total DR Capital Raised
Apr 11, 2008 3.92 1,815,204
0
1,815,204
7,115,600
0
7,115,600

No DR Special Notices are available.

No DR Events are available.

Data provided by Thomson Reuters

Recent Dividends & Distributions

More
US RECORD DATE US PAYABLE DATE NET DR AMOUNT
Jun 09, 2015 Jul 01, 2015 0.2200
Jun 10, 2014 Jul 01, 2014 0.2200
Jun 10, 2013 Jul 01, 2013 0.2000
Jun 08, 2012 Jun 22, 2012 0.1500

Institutional Ownership

TOP INSTITUTIONAL HOLDERS POSITION
Perceptive Advisors LLC 1,790,000
Hunter Associates Investment Management LLC 87,582
Moss Adams Wealth Advisors LLC 25,666
TOP MUTUAL FUND HOLDERS POSITION
Fidelity Nasdaq Composite Index Fund 16,642

Data provided by FactSet Research Systems Inc.

DR Details

DR Symbol TRIB
CUSIP 896438504
DR Venue NASDAQ Stock Market
DR ISIN US8964385046
Ratio DR:ORD 1:20
Local Exchange Not Traded
Underlying ISIN IE0006765089
Underlying SEDOL 0676508
Country Ireland
Effective Date Oct 28, 1992
Depositary BK (Sponsored)
Industry HealthCareEquip.&Ser
Books Open/Closed Open
Trinity Biotech plc is an Ireland-based commercial stage biotechnology company. The Company is focused on human diagnostics and diabetes management solutions, including wearable biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market and has also entered the wearable biosensor industry. It intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product.

Data provided by Mergent, Inc.

Fee Type in US Dollar per ADS Deposit Agreement
Annual Depositary Service up to $0.0000
Cancellation up to $0.1000
Cash Distribution up to $0.0200
Issuance up to $0.1000
Registrar Inspection up to $0.0000
Cash Distribution(Other) up to $0.0200
Rights - Issuance up to $0.1000
Stock Dividend up to $0.1000
Transfer up to $1.5000
Cable Fee per Cancellation $17.5000

Monthly Trading Summary

More
Month Month End DR Close Price DR Trading Volume Avg Day DR Trading Volume
Sep.25 1.04 3,561,381 169,590
Aug.25 1.46 271,388,360 12,923,255
Jul.25 0.69 3,921,287 178,240

Powered by FactSet Research Systems Inc.

This information and data is provided for general informational purposes only.  Certain displayed prices may not reflect direct quotes from any market or exchange, but may instead reflect an approximation of price based on a methodology that includes a calculation that includes the price of underlying securities and foreign exchange rate selected for such purpose. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to Terms of Use

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE